Current understanding of the equine immune response to Rhodococcus equi. An immunological review of R. equi pneumonia

Veterinary Immunology and Immunopathology

Volumn 135, Issue 1-2, 2010, Pages 1-11

  Dawson, Tamsin R M Y ^a   Horohov, David W ^b   Meijer, Wim G ^c   Muscatello, Gary ^d  

^a UNIVERSITY OF SUNDERLAND   (United Kingdom)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Adjuvants; Foals; Humoral; Hyperimmune plasma; Innate and cell mediated immunity; Rhodococcus equi; Vaccines

Indexed keywords

BACTERIAL VACCINE; BCG VACCINE; DNA VACCINE; GAMMA INTERFERON; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOLOGICAL ADJUVANT; PEPTIDE VACCINE;

ANIMAL HUSBANDRY; BACTERIAL PNEUMONIA; BRONCHOPNEUMONIA; CELLULAR IMMUNITY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG TREATMENT FAILURE; FOAL; HORSE DISEASE; HOST SUSCEPTIBILITY; HUMORAL IMMUNITY; IMMUNOPROPHYLAXIS; INNATE IMMUNITY; LOW DRUG DOSE; NEUTROPHIL; NONHUMAN; OPSONIZATION; POLLUTION; REVIEW; RHODOCOCCUS EQUI; TH1 CELL; TH2 CELL; VACCINATION;

ACTINOMYCETALES INFECTIONS; ANIMALS; ANIMALS, NEWBORN; BACTERIAL VACCINES; HORSE DISEASES; HORSES; IMMUNITY, HUMORAL; IMMUNITY, INNATE; PNEUMONIA, BACTERIAL; RHODOCOCCUS EQUI;

EQUIDAE; RHODOCOCCUS EQUI;

EID: 77951207496     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2009.12.004     Document Type: Review

References (142)

1. Adkins B., Leclerc C., Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat. Rev. Immunol. 2004, 4:553-564.
2. Almeida D.E., Colvin C.J., Coussens P.M. Antigen-specific regulatory T cells in bovine paratuberculosis. Vet. Immunol. Immunopathol. 2008, 125:234-245.
3. Amati L., Pepe M., Passeri M.E., Mastronardi M.L., Jirillo E., Covelli V. Toll-like receptor signalling mechanisms involved in dendritic cell activation: potential therapeutic control of T cell polarization. Curr. Pharm. Des. 2006, 12:4247-4254.
4. Barton M.D., Hughes K.L. Ecology of Rhodococcus equi. Vet. Microbiol. 1984, 9:65-76.
5. Becu T., Polledo G., Gaskin J.M. Immunoprophylaxis of Rhodococcus equi pneumonia in foals. Vet. Microbiol. 1997, 56:193-204.
6. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 2004, 430:257-263.
7. Boyd N.K., Cohen N.D., Lim W.S., Martens R.J., Chaffin M.K., Ball J.M. Temporal changes in cytokine expression of foals during the first month of life. Vet. Immunol. Immunopathol. 2003, 92:75-85.
8. Breathnach C.C., Sturgill-Wright T., Stiltner J.L., Adams A.A., Lunn D.P., Horohov D.W. Foals are interferon gamma deficient at birth. Vet. Immunol. Immunopathol. 2006, 112:199-209.
9. Caston S.S., McClure S.R., Martens R.J., Chaffin M.K., Miles K.G., Griffith R.W., Cohen N.D. Effect of hyperimmune plasma on the severity of pneumonia caused by Rhodococcus equi in experimentally infected foals. Vet. Ther. 2006, 7:361-375.
10. Cauchard J., Sevin C., Ballet J., Taouji S. Foal IgG and opsonising anti-Rhodococcus equi antibodies after immunisation of pregnant mares with a protective VapA candidate vaccine. Vet. Microbiol. 2004, 104:73-81.
11. Cauchard J., Taouji S., Sevin C., Duquesne F., Bernabe M., Laugier C., Ballet J.J. Immunogenicity of synthetic Rhodococcus equi virulence-associated protein peptides in neonate foals. Int. J. Med. Microbiol. 2006, 296:389-396.
12. Chaffin K.M., Cohen N.D., Martens R.J. Evaluation of equine breeding farm characteristics as risk factors for development of Rhodococcus equi pneumonia in foals. J. Am. Vet. Med. Assoc. 2003, 222:467-474.
13. Chen L., Cohen A.C., Lewis D.B. Impaired allogeneic activation and T-helper 1 differentiation of human cord blood naive CD4 T cells. Biol. Blood Marrow Transplant. 2006, 12:160-171.
14. Clough N.C., Roth J.A. Helper T lymphocyte subsets. Understanding Immunology 1998, Elsevier Books, Oxford, pp. 102-106.
15. Cox J.C., Coulter A.R. Adjuvants-a classification and review of their modes of action. Vaccine 1997, 15:248-256.
16. Crouch C.F., Daly J., Hannant D., Wilkins J. Immune response and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing 'American lineage' H3N8 virus. Vaccine 2004, 23:418-425.
17. Darrah P.A., Monaco M.C.G., Jain S., Hondalus M.K., Golenbock D.T., Mosser D.M. Innate immune responses to Rhodococcus equi. J. Immunol. 2004, 173:1914-1924.
18. Dascher C., Hiromatsu K., Xiong X., Morehouse C., Watts G., Liu G., McMurray D., LeClair K., Porcelli S., Brenner M. Immunisation with a mycobacterial lipid vaccine improves pulmonary pathology in the guinea pig model of tuberculosis. Int. Immunol. 2003, 15:915-925.
19. Dawson T.R.M.Y., Carter N., Cunningham A.C. A double blind study comparing the effect of hyperimmune plasma and standard equine plasma on reducing the incidence of Rhodococcus equi infection and requirement for treatment on an endemic stud farm. Proceedings of the 4th Havemeyer Workshop on Rhodococcus equi 2008, 71.
20. De Wit D., Tonon S., Olislagers V., Goriely S., Boutriaux M., Goldman M., Willems F. Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood. J. Autoimmun. 2003, 21:277-281.
21. De Wit D., Olislagers V., Goriely S., Vermeulen F., Wagner H., Goldman M., Willems F. Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns. Blood 2004, 103:1030-1032.
22. Demmers S., Johannisson A., Grondahl G., Jensen-Waern M. Neutrophil functions and serum IgG in growing foals. Equine Vet. J. 2001, 33:676-680.
23. Fermaglich, D.H., 2003. The effect of ageing in the immune response to vaccination in the horse. Master of Science Thesis. Veterinary Medical Sciences Department of Pathobiological Sciences, Louisiana State University.
24. Fernandez A.S., Prescott J.F., Nicholson V.M. Protective effect against Rhodococcus equi infection in mice of IgG purified from horses vaccinated with virulence associated protein (VapA) enriched antigens. Vet. Microbiol. 1997, 56:187-192.
25. Flaminio M.J., Rush B.R., Davis E.G., Hennessy K., Shuman W., Wilkerson M.J. Characterization of peripheral blood and pulmonary leukocyte function in healthy foals. Vet. Immunol. Immunopathol. 2000, 73:267-285.
26. Flaminio M.J.B.F., Borges A.S., Nydam D.V., Horohov D.Q., Hecker R., Matychak M.B. The effect of CpG-ODN on antigen presenting cells of the foal. J. Immun. Based Ther. Vacc. 2007, 5:1-17.
27. Flaminio M.J., Nydam D.V., Marquis H., Matychak M.B., Giguere S. Foal monocyte-derived dendritic cells become activated upon Rhodococcus equi infection. Clin. Vacc. Immunol. 2009, 16:176-183.
28. Fujihashi K., McGhee J.K., Lue C., Beagley K.W., Taga T., Hirano T., Kishimoto T., Mestecky J., Kiyono H. Human appendix B cells naturally express receptors for and respond to interleukin 6 with selective IgA1 and IgA2 synthesis. J. Clin. Invest. 1991, 88:248-252.
29. Garton N.J., Gilleron M., Brando T., Dan H., Giguere S., Puzo G., Prescott J.F., Sutcliffe I.C. A novel lipoarabinomannan from the equine pathogen Rhodococcus equi. J. Biol. Chem. 2002, 277:31722-31733.
30. Giguere S., Wilkie B.N., Prescott J.F. Modulation of cytokine response of pneumonic foals by virulent Rhodococcus equi. Infect. Immun. 1999, 67:5041-5047.
31. Giguere S., Gaskin J.M., Miller C., Bowman J.L. Evaluation of a commercially available hyperimmune plasma product for prevention of naturally acquired pneumonia caused by Rhodococcus equi in foals. J. Am. Vet. Med. Assoc. 2002, 220:59-63.
32. Giguere S., Hernandez J., Gaskin J., Prescott J.F., Takai S., Miller C. Performance of five serological assays for diagnosis of Rhodococcus equi pneumonia in foals. Clin. Diagn. Lab. Immunol. 2003, 10:241-245.
33. Granucci F., Foti M., Ricciardi-Castagnoli P. Dendritic cell biology. Adv. Immunol. 2005, 88:193-233.
34. Grimm M.B., Cohen N.D., Slovis N.M., Mundy G.D., Harrington J.R., Libal M.C., Takai S., Martens R.J. Evaluation of faecal samples from mares as a source of Rhodococcus equi for their foals by use of quantitative bacteriologic culture and colony immunoblot analyses. Am. J. Vet. Res. 2007, 68:63-71.
35. Grondahl G., Johannisson A., Jensen-Waern M. Opsonic effect of plasma from different donors. Vet. Microbiol. 1997, 56:227-235.
36. Grondahl G., Johanisson A., Demmers S., Jensen-Waern M. Influence of age and plasma treatment on neutrophil phagocytosis and CD18 expression in foals. Vet. Microbiol. 1999, 65:241-254.
37. Grondahl G., Sternberg S., Waern M.J., Johanisson A. Opsonic capacity of foal serum for the two neonatal pathogens Escherichia coli and Actinobacillus equuli. Equine Vet. J. 2001, 33:670-675.
38. Haghighi H.R., Prescott J.F. Assessment in mice of VapA-DNA vaccination against Rhodococcus equi infection. Vet. Immunol. Immunopathol. 2005, 104:215-225.
39. Hietala S.K., Ardans A.A. Interaction of Rhodococcus equi with phagocytic cells from R. equi-exposed and non-exposed foals. Vet. Microbiol. 1987, 14:307-320.
40. Higuchi T., Arakawa T., Hashikura S., Inui T., Takai S. Effect of prophylactic administration of hyperimmune plasma to prevent Rhodococcus equi infection on foals from endemically affected farms. J. Vet. Med. B: Infect. Dis. Vet. Public Health 1999, 46:641-648.
41. Hines S.A., Kanaly S.T., Byrne B.A., Palmer G.H. Immunity to Rhodococcus equi. Vet. Microbiol. 1997, 56:177-185.
42. Hines M.T., Paasch K.M., Alperin D.C., Palmer G.H., Westhoff N.C., Hines S.A. Immunity to Rhodococcus equi: antigen-specific recall responses in the lungs of adult horses. Vet. Immunol. Immunopathol. 2001, 79:101-113.
43. + T lymphocytes. Clin. Diagn. Lab. Immunol. 2003, 10:208-215.
44. Holznagel D.L., Hussey S., Mihalyi J.E., Wilson W.D., Lunn D.P. Onset of immunoglobulin production in foals. Equine Vet. J. 2003, 35:620-622.
45. Hooper-McGrevy K.E., Giguere S., Wilkie B.N., Prescott J.F. Evaluation of equine immunoglobulin specific Rhodococcus equi virulence-associated proteins A and C for use in protecting foals against Rhodococcus equi-induced pneumonia. Am. J. Vet. Res. 2001, 62:1307-1313.
46. Hooper-McGrevy K.E., Wilkie B.N., Prescott J.F. Immunoglobulin G subisotype responses of pneumonic and healthy exposed foals and adult horses to Rhodococcus equi virulence associated proteins. Clin. Diagn. Lab. Immunol. 2003, 10:345-351.
47. Hooper-McGrevy K.E., Wilkie B.N., Prescott J.F. Virulence-associated protein-specific serum immunoglobulin G-isotype expression in young foals protected against Rhodococcus equi pneumonia by oral immunization with virulent R. equi. Vaccine 2005, 23:5760-5767.
48. Horohov D.W. Equine cytokines: past, present and future. J. Equine Vet. Sci. 2003, 23:331-332.
49. Horowitz M.L., Cohen N.D., Takai S., Becu T., Chaffin K.M., Chu K.K., Magdesian K.G., Martens R.J. Application of Sartwell's model (lognormal distribution of incubation periods) to age at onset and age at death of foals with Rhodococcus equi pneumonia as evidence of perinatal infection. J. Vet. Intern. Med. 2001, 15:171-175.
50. Hughes K.L., Sulaiman I. The ecology of Rhodococcus equi and physiochemical influences on growth. Vet. Microbiol. 1987, 14:241-250.
51. Hurley J.R., Begg A.P. Failure of Hyperimmune plasma to prevent pneumonia caused by Rhodococcus equi in foals. Aust. Vet. J. 1995, 72:418-420.
52. Jacks S., Giguere S., Crawford P.C., Castleman W.L. Experimental infection of neonatal foals with Rhodococcus equi triggers adult-like gamma interferon induction. Clin. Vacc. Immunol. 2007, 14:669-677.
53. Jacks S., Giguere S., Prescott J.F. In vivo expression of cell-mediated immune responses to plasmid encoded virulence-associated proteins of Rhodococcus equi in foals. Clin. Vacc. Immunol. 2007, 14:369-374.
54. Jain S., Bloom B.R., Hondalus M.K. Deletion of vapA encoding virulence associated protein A attenuates the intracellular actinomycete Rhodococcus equi. Mol. Microbiol. 2003, 50:115-128.
55. + lymphocyte-deficient transgenic mice. Infect. Immun. 1993, 61:4929-4932.
56. Kanaly S.T., Hines S.A., Palmer G.H. Cytokine modulation alters pulmonary clearance of Rhodococcus equi and development of granulomatous pneumonia. Infect. Immun. 1995, 63:3037-3041.
57. Kasuga-Aoki H., Takai S., Sasaki Y., Tsubaki S., Madarame H., Nakane A. Tumour necrosis factor and interferon-γ are required in host resistance against virulent Rhodococcus equi infection in mice: cytokine production depends on the virulence levels of R. equi. Immunology 1999, 96:122-127.
58. Kidd, P., 2003. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Alternative Medicine Review. http://findarticles.com/p/articles/mi_m0FDN/is_3_8/ai_107835434.
59. Kohn C.W., Knight D., Hueston W., Jacobs R., Reed S.M. Colostral and serum IgG, IgA, and IgM concentrations in Standardbred mares and their foals at parturition. J. Am. Vet. Med. Assoc. 1989, 195:64-68.
60. Kotiranta-Ainamo A., Rautonen J., Rautonen N. Imbalanced cytokine secretion in newborns. Biol. Neonate 2004, 85:55-60.
61. Langner K.F.A., Darpel K.E., Drolet B.S., Fischer A., Hampel S., Heselhaus J.E., Mellor P.S., Mertens P.P.C., Leinbold W. Comparison of cellular and humoral immunoassays for the assessment of summer eczema in horses. Vet. Immunol. Immunopathol. 2008, 122:126-137.
62. Lavoie J.P., Spensley M.S., Smith B.P., Mihalyi J. Absorption of bovine colostral immunoglobulins G and M in newborn foals. Am. J. Vet. Res. 1989, 50:1598-1603.
63. Lewis M.J., Wagner B., Woof J.M. The different effector function capabilities of the seven equine IgG subclasses have implications for vaccine strategies. Mol. Immunol. 2008, 45:818-827.
64. Lopez A.M., Hines M.T., Palmer G.H., Alperin D.C., Hines S.A. Identification of pulmonary T-lymphocyte and serum antibody isotype responses associated with protection against Rhodococcus equi. Clin. Diagn. Lab. Immunol. 2002, 9:1270-1276.
65. Lopez A.M., Hines M.T., Palmer G.H., Knowles D.P., Alperin D.C., Hines S.A. Analysis of anamnestic immune responses in adult horses and priming in neonates induced by a DNA vaccine expressing the VapA gene in Rhodococcus equi. Vaccine 2003, 21:3815-3825.
66. Lopez A.M., Townsend H.G.G., Allen A.L., Hondalus M.K. Safety and immunogenicity of a live-attenuated auxotrophic candidate vaccine against the intracellular pathogen Rhodococcus equi. Vaccine 2008, 26:998-1009.
67. Lucisano Y.M., de-Mello A.M., Vasques E.R., Mantovani B. Precipitated immune complexes of IgM induce the generation of reactive oxygen species in rabbits. Braz. J. Med. Biol. Res. 1998, 31:793-797.
68. Lunn D.P., Soboll G., Schram B.R., Quass J., McGregor M.W., Drape R.J., Macklin M.D., Swain W.F., Olsen C.W. Antibody response to DNA vaccination of horses using influenza virus haemagglutinin gene. Vaccine 1999, 17:2245-2258.
69. Madigan J.E., Hietala S., Muller N. Protection against naturally acquired Rhodococcus equi pneumonia in foals by administration of Hyperimmune plasma. J. Reprod. Fertil. Suppl. 1991, 44:571-578.
70. Madigan J. Plasma-how and when to use it. Proceedings of the Rossdale and Partners Foal Care Course 2008, 131-132.
71. Marodi L. Innate cellular immune responses in newborns. Clin. Immunol. 2006, 118:137-144.
72. Martens J.G., Martens R.J., Renshaw H.W. Rhodococcus (Corynebacterium) equi: bactericidal capacity of neutrophils from neonatal and adult horses. Am. J. Vet. Res. 1988, 49:295-299.
73. Martens R.J., Martens J.G., Fiske R.A., Hietala S.K. Rhodococcus equi foal pneumonia: protective effects of immune plasma in experimentally infected foals. Equine Vet. J. 1989, 21:249-255.
74. Martens R.J., Martens J.G., Fiske R.A. Failure of passive immunisation by colostrums from immunised mares to protect foals against Rhodococcus equi pneumonia. Equine Vet. J. Suppl. 1991, 12:19-22.
75. Martens R.J., Cohen N.D., Chaffin K.M. Evaluation of 5 serological assays to detect Rhodococcus equi pneumonia in foals. J. Am. Vet. Med. Assoc. 2002, 221:825-833.
76. Martens R.J., Cohen N.D., Jones S.L., Moore T.A., Edwards J.F. Protective role of neutrophils in mice experimentally infected with Rhodococcus equi. Infect. Immun. 2005, 73:7040-7042.
77. McClure J.T., DeLuca J.L., Miller J. Comparison of five screening tests for detection of failure of passive transfer in foals. J. Vet. Intern. Med. 2002, 16:336. ACVIM 20th Annual Veterinary Medical Forum Abstract Program.
78. McFarlane D., Sellan D.C., Gibbs S.A. Age-related quantitative alterations in lymphocyte subsets and immunoglobulin isotypes in healthy horses. Am. J. Vet. Res. 2001, 62:1413-1417.
79. McGuire T.C., Crawford T.B. Passive immunity in the foal: measurement of specific immunoglobulin classes and specific antibody. Am. J. Vet. Res. 1973, 34:1299-1303.
80. McGuire T.C., Crawford T.B., Hallowell A.L., Macomber L.E. Failure of colostral immunoglobulin transfer as an explanation for most infections and deaths in neonatal foals. J. Am. Vet. Med. Assoc. 1977, 170:1302-1304.
81. McTaggart C., Yovich J.V., Penhale J., Raidal S.L. A comparison of foal and adult horse neutrophil function using flow cytometric techniques. Res. Vet. Sci. 2001, 71:73-79.
82. McTaggart C., Penhale J., Raidal S.L. Effect of plasma transfusion on neutrophil function in healthy and septic foals. Aust. Vet. J. 2005, 83:499-505.
83. Mealey R.H., Stone D.M., Hines M.T., Alperin D.C., Littke M.H., Leib S.R., Leach S.E., Hines S.A. Experimental Rhodococcus equi and equine infections anaemia virus DNA vaccination in adult and neonatal horses: effect of IL-12, dose and route. Vaccine 2007, 25:7582-7597.
84. Mérant C., Breathnach C., Kohler K., Rashid C., Van Meter P., Horohov D. Young foal and adult horse monocyte-derived dendritic cells differ by their degree of phenotypic maturity. Vet. Immunol. Immunopathol. 2009, 131:1-8.
85. Morris D.D., Meirs D.A., Merryman G.C. Passive transfer failure in horses: incidence and causative factors on a breeding farm. Am. J. Vet. Res. 1985, 46:2294-2299.
86. Mosmann T.R., Coffman R.L. Th1 and Th2 cells: different patterns of lymphokine secretions lead to different functional properties. Annu. Rev. Immunol. 1989, 7:145-173.
87. Muscatello G., Gerbaud S., Kennedy C., Gilkerson J.R., Buckley T., Klay M., Leadon D.P., Browning G.F. Comparison of concentrations of Rhodococcus equi and virulent R. equi in air of stables and paddocks on horse breeding farms in a temperate climate. Equine Vet. J. 2006, 38:263-265.
88. Muscatello G., Anderson G.A., Gilkerson J.R., Browning G.F. Associations between the ecology of virulent Rhodococcus equi and the epidemiology of R. equi pneumonia on Australian Thoroughbred farms. Appl. Environ. Microbiol. 2006, 72:6152-6160.
89. Muscatello, G., Gilkerson, J.R., Browning, G.F., 2006c. Rattles in horses: Effects of stud management on ecology of virulent Rhodococcus equi. Rural Industries Research and Development Corporation, Australia.
90. Muscatello G., Leadon D.P., Klay M., Ocampo-Sosa A., Lewis D.A., Fogarty U., Buckley T., Gilkerson J.R., Meijer W.G., Vazquez-Boland J.A. Rhodococcus equi infection in foals: the science of 'rattles'. Equine Vet. J. 2007, 39:470-478.
91. Muscatello G., Gilkerson J.R., Browning G.F. Detection of virulent Rhodococcus equi in exhaled air samples from naturally infected foals. J. Clin. Microbiol. 2009, 47:734-737.
92. Nally J.E., Artiushin S., Sheoran A.S., Burns P.J., Simon B., Gilley R.N., Gibson J., Sullivan S., Timoney J.F. Induction of mucosal and systemic antibody specific for SEMF3 of Streptococcus equi by intranasal vaccination using sucrose acetate isobutyrate based delivery system. Vaccine 2000, 19:492-497.
93. Netea M.G., van der Graaf C., van der Meer J.W.M., Kullberg B.J. Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system. J. Leukoc. Biol. 2004, 75:749-755.
94. Nicolson L., McMonagle L., Taylor S., Hopkins C., Sanders L., van Kuilekom H., Scholtes N., Argyle D., Onions D., Schijns V. Equine cytokines and associated reagents. Proceedings of a Workshop on Equine Immunology, Havemeyer Foundation Monograph Series No. 4 2001, 57-58.
95. Nordengrahn A., Rusvai M., Merza M., Ekstrom J., Morein B., Belak S. Equine herpesvirus type 2 (EHV-2) as a predisposing factor for Rhodococcus equi pneumonia in foals: prevention of the bifactorial disease with EHV-2 immunostimulating complexes. Vet. Microbiol. 1996, 51:55-68.
96. Nordmann P., Ronco E., Nauciel C. Role of T lymphocyte subsets in Rhodococcus equi infection. Infect. Immun. 1992, 60:2748-2752.
97. Nordmann P., Ronco E., Guenounou M. Involvement of interferon-gamma and tumor necrosis factor-alpha in host defense against Rhodococcus equi. J. Infect. Dis. 1993, 167:1456-1459.
98. Ocampo-Sosa A.A., Lewis D.A., Navas J., Quigley F., Callejo R., Scortti M., Leadon D.P., Fogarty U., Vazquez-Boland J.A. Molecular epidemiology of Rhodococcus equi based on traA, vapA and vapB virulence plasmid markers. J. Infect. Dis. 2007, 196:763-769.
99. Oliveira A.F., Ferraz L.C., Brocchi M., Roque-Barreira M.-C. Oral administration of a live attenuated Salmonella vaccine strain expressing the VapA protein induces protection against infection by Rhodococcus equi. Microbes Infect. 2007, 9:382-390.
100. Patton K.M., McGuire T.C., Hines M.T., Mealey R.H., Hines S.A. Rhodococcus equi specific cytotoxic T lymphocytes in immune horses and development in asymptomatic foals. Infect. Immun. 2005, 73:2083-2093.
101. Pargass I.S., Wills T.B., Davis W.C., Wardrop K.J., Alperin D.C., Hines S.A. The influence of age and Rhodococcus equi infection on CD1 expression by equine antigen presenting cells. Vet. Immunol. Immunopathol. 2009, 130:197-209.
102. Perkins G.A., Yeager A., Erb H.N., Nydam D.V., Divers T.J., Bowman J.L. Survival of foals with experimentally induced Rhodococcus equi infection given either hyperimmune plasma containing R. equi antibody or normal equine plasma. Vet. Ther. 2002, 3:334-346.
103. Perryman L.E., McGuire T.C. Evaluation for immune system failures in horses and ponies. J. Am. Vet. Med. Assoc. 1980, 176:1374-1377.
104. Phumoonna T., Barton M.D., Vanniasinkam T., Heuzenroeder M.W. Chimeric vapA/groEL2 DNA vaccines enhance the clearance of Rhodococcus equi in aerosol challenged C3H/He mice. Vaccine 2008, 26:2457-2465.
105. Pleass R.J., Lang M.L., Kerr M.A., Woof J.M. IgA is a more potent inducer of NADPH oxidase activation and degranulation in blood eosinophils than IgE. Mol. Immunol. 2007, 44:1401-1408.
106. Power C.A., Wei G., Bretscher P.A. Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunisation is administered by the intravenous, subcutaneous or intradermal route. Infect. Immun. 1998, 66:5743-5750.
107. Prescott J.F., Travers M., Yager-Johnson J.A. Epidemiological survey of Corynebacterium equi infections on five Ontario horse farms. Can. J. Comp. Med. 1984, 48:10-13.
108. Prescott J.F., Patterson M.C., Nicholson V.M., Morein B., Yager J.A. Assessment of the immunogenic potential of Rhodococcus equi virulence associated protein (VapA) in mice. Vet. Microbiol. 1997, 56:213-225.
109. Ren J., Prescott J.F. Analysis of virulence plasmid gene expression of intra-macrophage and in vitro grown Rhodococcus equi ATCC 33701. Vet. Microbiol. 2003, 94:167-182.
110. Ren J., Prescott J.F. The effect of mutation on Rhodococcus equi virulence plasmid gene expression and mouse virulence. Vet. Microbiol. 2004, 103:219-230.
111. Russell D.A., Byrne G.A., O'Connell E.P., Boland C.A., Meijer W.G. The LysR-type transcriptional regulator VirR is required for expression of the virulence gene vapA of Rhodococcus equi ATCC 33701. J. Bacteriol. 2004, 186:5576-5584.
112. Ryan C., Giguere S., Hagen J., Hartnett C., Kalyuzhny A.E. Effect of age and mitogen on the frequency of interleukin-4 and interferon gamma secreting cells in foals and adult horses as assessed by an equine-specific ELISPOT assay. Vet. Immunol. Immunopathol. 2010, 133:66-71.
113. + T cells participate in the memory immune response to Mycobacterium tuberculosis. Infect. Immun. 2001, 69:4320-4328.
114. Schelonka R.L., Infante A.J. Neonatal immunology. Semin. Perinatol. 1998, 22:2-14.
115. Sheoran A.S., Homes M.A. Separation of equine IgG subclasses (IgGa, IgGb and IgGT) using their differential binding characteristics for staphylococcus protein A and streptococcal protein G. Vet. Immunol. Immunopathol. 1996, 55:33-43.
116. Sheoran A.S., Timoney J.F., Holmes M.A., Karzenski S.S., Crisman M.V. Immunoglobulin isotypes in sera and nasal mucosal secretions and their neonatal transfer and distribution in horses. Am. J. Vet. Res. 2000, 61:1099-1105.
117. Siegrist C. Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine 2003, 21:3406-3412.
118. Sieling P.A., Chatterjee D., Porcelli S.A., Prigozy T.I., Mazzaccaro R.J., Soriano T., Bloom B.R., Vrenner M.B., Kronenberg M., Brennan P.J. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 1995, 269:227-230.
119. Simpson C.C., Woods G.M., Muller H.K. Impaired CD40-signalling in Langerhans' cells from murine neonatal draining lymph nodes: implications for neonatally induced cutaneous tolerance. Clin. Exp. Immunol. 2003, 132:201-208.
120. Soboll G., Horohov D.W., Aldridge B.M., Olsen C.W., McGregor M.W., Drape R.J., Macklin M.D., Swain W.F., Lunn D.P. Regional antibody and cellular immune responses to equine influenza virus infection, and particle DNA mediated vaccination. Vet. Immunol. Immunopathol. 2003, 94:47-62.
121. Sponseller B.A., de Macedo M.M., Clark S.K., Gallup J.M., Jones D.E. Activation of peripheral blood monocytes results in more robust production of IL-10 in neonatal foals compared to adult horses. Vet. Immunol. Immunopathol. 2009, 127:167-173.
122. Steinman R.M., Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr. Top. Microbiol. Immunol. 2006, 311:17-58.
123. Takai S., Ohkura H., Watanabe T., Tsubaki S. Quantitative aspects of fecal Rhodococcus (Corynebacterium) equi in foals. J. Clin. Microbiol. 1986, 23:794-796.
124. Takai S., Kawazu S., Tsubaki S. Humoral immune responses of foals to experimental infection with R. equi. Vet. Microbiol. 1987, 14:321-327.
125. Takai S., Koike K., Ohbushi S., Izumi C., Tsubaki S. Identification of 15- to 17-kilodalton antigens associated with virulent Rhodococcus equi. J. Clin. Microbiol. 1991, 29:439-443.
126. Takai S., Ohbushi S., Koike K., Tsubaki S., Oishi H., Kamada M. Prevalence of virulent Rhodococcus equi in isolates from soil and feces of horses from horse-breeding farms with and without endemic infections. J. Clin. Microbiol. 1991, 29:2887-2889.
127. Takai S., Takahagi J., Sato Y., Yamaguchi K., Kakizaki S., Takehara F., Matsukura S., Tamada Y., Tani A., Sasaki Y., Tsubaki S., Kamada M. Molecular epidemiology of virulent Rhodococcus equi in horses and their environments. Equine Infectious Disease VII 1994, 183-187. R & W Publications, Newmarket. H. Nakajima, W. Plowright (Eds.).
128. Takai S., Hidaka D., Fujii M., Shindoh Y., Murata T., Nakanishi S., Sasaki Y., Tsubaki S., Kamada M. Serum antibody responses of foals to virulence-associated 15- to 17-kilodalton antigens of Rhodococcus equi. Vet. Microbiol. 1996, 52:63-71.
129. Takai S. Live virulent Rhodococcus equi, rather than killed or avirulent, elicits protective immunity to R. equi infection in mice. FEMS Immunol. Med. Microbiol. 1998, 24:1-9.
130. Takai S., Kobayashi C., Murakami K., Sasaki Y., Tsubaki S. Live virulent Rhodococcus equi, rather than killed or avirulent, elicits protective immunity to R. equi in mice. FEMS Immunol. Med. Microbiol. 1999, 24:1-9.
131. Takai S., Hines S.A., Sekizaki T., Nicholson V.M., Alperin D.A., Osaki M., Osaki D., Nakamura M., Suzuki K., Ogino N., Kakuka T., Dan H., Prescott J.F. DNA sequence and comparison of virulence plasmids from Rhodococcus equi ATCC 33701 and 103. Infect. Immun. 2000, 68:6840-6847.
132. Taouji S., Breard E., Peyret-Lacombe A., Pronost S., Fortier G., Collobert-Laugier C. Serum and mucosal antibodies of infected foals recognized by two distinct epitopes of VapA of Rhodococcus equi. FEMS Immunol. Med. Microbiol. 2002, 34:299-306.
133. Taouji S., Nomura I., Giguere S., Tomomitsu S., Kakuda T., Ganne V., Takai S. Immunogenicity of synthetic peptides representing B-cell epitopes of VapA of Rhodococcus equi. Vaccine 2004, 22:1114-1122.
134. + T cells requires production of gamma interferon. Infect. Immun. 1998, 66:830-834.
135. Tizard I.R. Dendritic cells and antigen processing. Veterinary Immunology: An Introduction 2008, Saunders, Philadelphia, pp. 89-100. eighth ed.
136. van Vliet S.J., den Dunnen J., Gringhuis S.I., Geijtenbeek T.B., van Kooyk Y. Innate signalling and regulation of dendritic cell immunity. Curr. Opin. Immunol. 2007, 19:435-440.
137. Vanniasinkam T., Barton M.D., Heuzenroeder M.W. The immunogenicity of Rhodococcus equi GroEL2-based vaccines in a murine model. Vet. Immunol. Immunopathol. 2003, 98:91-100.
138. Vanniasinkam T., Barton M.D., Heuzenroeder M.W. Immune responses to vaccines based upon the VapA protein of the horse pathogen, Rhodococcus equi, in a murine model. Int. J. Med. Microbiol. 2005, 294:437-445.
139. Varga J., Fodor L., Rusvai M., Soos I., Makrai L. Prevention of Rhodococcus equi pneumonia of foals using two different inactivated vaccines. Vet. Microbiol. 1997, 56:205-212.
140. Wagner B., Miller D.C., Lear T.L., Antczak D.F. The complete map of the immunoglobulin heavy chain constant gene region reveals evidence for seven IgG isotypes and for IgD in the horse. J. Immunol. 2004, 173:3230-3242.
141. Wagner B. Immunoglobulins and immunoglobulin genes of the horse. Dev. Comp. Immunol. 2006, 30:155-164.
142. Zhou Y. Regulatory T cells and viral infections. Front. Biosci. 2008, 13:1152-1170.